Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
Protocol ID
ARST2032
Disease (Sub Disease)
Rhabdomyosarcoma
Diagnosis Stage
Newly diagnosed
Location
NSW, WA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
Perth Children's Hospital
The Children's Hospital at Westmead
Christchurch Hospital
The Children's Hospital at Westmead
Christchurch Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 21 years
International registry ID's
NCT05304585
| Study Title | A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma |
|---|---|
| Protocol ID | ARST2032 |
| Disease (Sub Disease) | Rhabdomyosarcoma |
| Diagnosis Stage | Newly diagnosed |
| Location | NSW / WA / NZ |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT05304585 |
| Trial Status | Open |
| Trial Open Date | 09/12/2022 |
| Sites | Perth Children's Hospital/ The Children's Hospital at Westmead/ Christchurch Hospital |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 21 years |
| International registry ID's | NCT05304585 |